Results

Total Results: over 10,000 records

Showing results for "weight".
Users also searched for: obesity screening

  1. hcup-us.ahrq.gov/reports/statbriefs/sb296-Payers-Maternal-ED-2019.pdf
    January 01, 2019 - Expected Payers and Patient Characteristics of Maternal Emergency Department Care, 2019 1 STATISTICAL BRIEF #296 June 2022 Kimberly W. McDermott, Ph.D., Lawrence D. Reid, Ph.D., and Pamela L. Owens, Ph.D. Introduction Maternal health coverage is an important element of health i…
  2. hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hospital-Conditions.jsp
    May 01, 2016 - Skin and subcutaneous tissue infections 718 1.1 110 1.5 17 Short gestation, low birth weight … Medicaid-covered stays: Cardiac and circulatory congenital anomalies Short gestation, low birth weight
  3. www.uspreventiveservicestaskforce.org/uspstf/recommendation/perinatal-depression-preventive-interventions
    February 12, 2019 - depression is linked to an increased risk of preterm birth, small for gestational age newborn, and low birth weight … fatty acids demonstrated small statistically significant improvements in gestational length, mean birth weight
  4. effectivehealthcare-admin.ahrq.gov/products/dietary-protein-intake/protocol
    June 02, 2023 - that aim to treat participants who have already been diagnosed with the outcome of interest (except weight
  5. www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-blood-pressure-in-adults-screening-monitoring-october-2015
    October 12, 2015 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement High Blood Pressure in Adults: Screening October 12, 2015 Recommendations made by the USPSTF are independent of the U.S. governmen…
  6. www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/perinatal-depression-preventive-interventions
    February 12, 2019 - depression is linked to an increased risk of preterm birth, small for gestational age newborn, and low birth weight … fatty acids demonstrated small statistically significant improvements in gestational length, mean birth weight
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
    November 28, 2023 - aim to treat participants who have already been diagnosed with the outcome of interest (except weight
  8. cds.ahrq.gov/taxonomy/term/69806
    August 23, 2024 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/bWme33U4raQYVZzafX8TjL
    August 01, 2005 - Decrease in birth weight in relation to maternal bone-lead burden. … O’Conno r, 199967 (Fair) Randomized placebo- controlled double-blind trial DMSA (child weight … <15 kg) 1,000 mg tid for 5 days, followed by 100 mg bid for 14 days DMSA (child weight >15 kg … For the anthropometric measures of maternal nutritional status, variables measuring gain in weight … (other significant birth weight predictors included maternal nutritional status, parity, education
  10. qualityindicators.ahrq.gov/Archive/News2009.aspx
    January 27, 2010 - Measures moved to other SAS modules – PSI 17 (Birth trauma – Injury to Neonate) and PQI 9 (Low Birth Weight
  11. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/pruprev/factraining_slides.pptx
    December 01, 2014 - Examples from Pressure Ulcer Prevention Reports: Nutrition Risk Report Risk criteria Meal consumption Weight
  12. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout Treatment
  13. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout
  14. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout
  15. www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout Treatment
  16. www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout
  17. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout Treatment
  18. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout Treatment
  19. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout
  20. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
    January 01, 2011 - Patients Treated With Medication for ADHD Should Have Their Height and Weight Monitored Throughout